WT06491I/Z/01/Z/WT_/Wellcome Trust/United Kingdom[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2006	1
2009	1
2010	2
2011	1
2025	0

Page 1

Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanoma.

Lladser A, Ljungberg K, Tufvesson H, Tazzari M, Roos AK, Quest AF, Kiessling R. Lladser A, et al. Cancer Immunol Immunother. 2010 Jan;59(1):81-92. doi: 10.1007/s00262-009-0725-4. Epub 2009 Jun 14. Cancer Immunol Immunother. 2010. PMID: 19526360 Free PMC article.

DAI (DLM-1/ZBP1) as a genetic adjuvant for DNA vaccines that promotes effective antitumor CTL immunity.

Lladser A, Mougiakakos D, Tufvesson H, Ligtenberg MA, Quest AF, Kiessling R, Ljungberg K. Lladser A, et al. Mol Ther. 2011 Mar;19(3):594-601. doi: 10.1038/mt.2010.268. Epub 2010 Dec 14. Mol Ther. 2011. PMID: 21157438 Free PMC article.

Casein kinase 2 (CK2) increases survivin expression via enhanced beta-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription.

Tapia JC, Torres VA, Rodriguez DA, Leyton L, Quest AF. Tapia JC, et al. Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15079-84. doi: 10.1073/pnas.0606845103. Epub 2006 Sep 27. Proc Natl Acad Sci U S A. 2006. PMID: 17005722 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year